Navigation Links
Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia

tcome. To confirm the effects of the novel RNA Antagonist SPC2996 on Bcl-2 levels in CLL patients, Bcl-2 mRNA levels were determined in extracted RNA from blood samples from patients in this study. As shown in figure 2 attached, there was a statistically significant down regulation of Bcl-2 mRNA (expressed as a ratio to 18S ribosomal RNA, a measure of total blood RNA) in patients receiving drug at 4mg/kg/infusion, over the 2 week course of therapy. Such patient data supports the view that SPC2996 is working through specific antagonism of Bcl-2 mRNA.

Safety

SPC2996 was well tolerated. All infusions were unproblematic and there were no signs of cytokine release or complement activation. Two patients had rises in serum alanine aminotransferase (ALT) following the last dose (i.e. after a total dose of 24mg/kg) which were transient and the patients recovered fully. Two cases of grade 3 thrombocytopaenia were reported. In the 2mg/kg/infusion group, one patient was diagnosed to have Tumour Lysis Syndrome following 2 infusions of drug.

- ENDS -

Annabel Entress Account Manager ----------------------------------------------------------------------------------------------- Direct line: +44 (0)20 7268 3234 Main tel: +44 (0)20 7268 3002 Fax: +44 (0)20 7268 3102 www.northbankcommunications.com <http://www.northbankcommunications.com>

Northbank Communications Ltd 85 Tottenham Court Road, London, W1T 4TQ UK

To see our latest newsletter, Newsbank, please click here <http://www.northbankcommunications.com/newsletter/newsletter.htm> .

This email and any attachments are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient you must not copy this
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:6/17/2013)... PAUL, Minn. , June 17, 2013 Prime ... branding and design agency, Larsen, was awarded the Silver Anvil ... Repositioning Prime Therapeutics." The award was presented at the Public ... Ceremony held June 13 at the AXA Equitable ... The Silver Anvil, which has been presented annually ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler ... company,s new X-4S pressure sensitive labeling head. The ... speed and performance requirements that serialization demands. ... WLS is uniquely qualified to work with pharmaceutical ... their serialization and track and trace implementation strategies. ...
(Date:6/17/2013)... Mass. and TORONTO , ... ) (OTCBB:GNBT) today announced that it entered into a ... 17, 2013.  The investors have agreed to purchase in ... the Company,s newly designated non-voting Series E 9% Convertible ... up to an aggregate of 100% of the shares ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
... 2011  IRIDEX Corporation (Nasdaq: IRIX ) today ... 10 years demonstrates the safety and efficacy of MicroPulse ... the retina tissue damage associated with conventional laser therapy.  ... and Prevention, DME, a swelling of retinal tissue, is ...
... Reportlinker.com announces that a new market ... Global Medical Ultrasound ... http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report analyzes ... in US$ Million by the following End-Use ...
Cached Medicine Technology:10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 210-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 3Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25
(Date:6/18/2013)... Case Medical Center clinical researchers have launched an ... will evaluate the ability of a patient,s own ... stage peripheral arterial disease (PAD). , Led ... at University Hospitals Case Medical Center,s Harrington Heart ... Case Western Reserve University School of Medicine, the ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 David Connett, ... of Family Medicine for the College of Osteopathic Medicine ... Sciences has been elected president of the Osteopathic ... G. Brown Jr. appointed Connett, a 1984 alumnus of ... members recently elected Connett to the position during a ...
(Date:6/18/2013)... fat cells in the mammary gland appear to provide ... early in life, and the subsequent development of breast ... the July 2013 issue of the journal Cancer ... may be associated with an increased risk of certain ... the biology of social stress to cancer have been ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... fatty liver disease (NAFLD) and non-alcoholic steatohepatitis ... disease leading to cirrhosis and hepatocellular carcinoma. ... significant efficacy in these conditions and no ... the renin-angiotensin system overexpression plays a central ...
... and family can pave the way to sporting victory, according ... Kelly Holmes and Sir Chris Hoy have both cited the ... factor in their Olympic success. Now, for the first time, ... on sports performance. , Published in the Journal ...
... Jeff Bingaman (D-NM) received the 2009 Outstanding Leadership ... (APAPO) for his advocacy work and legislative accomplishments ... given to a member of Congress who has ... Bingaman has been a tireless crusader of mental ...
... in the Diagnosis and Assessment of AsthmaEXTON, Pa., March ... Pharmaxis Ltd (ASX: PXS, Nasdaq: PXSL ), ... it has filed a New Drug Application (NDA), electronically, ... Aridol(TM) (mannitol bronchial challenge test). Bronchial challenge tests ...
... B. Snow Jr., chairman and chief executive officer, Medco ... scheduled to address the Barclays Capital Global Healthcare Conference ... the Loews Miami Beach Hotel, South Beach, will begin ... officer, is also scheduled to attend.The presentation may be ...
... Specially trained vets are using ancient treatment to fight ... After surgery for a ruptured disk two years ago, ... became lethargic and lost her appetite. , Things were ... 10-year-old to an acupuncturist, who treated her three times ...
Cached Medicine News:Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 2Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 3Health News:Study shows why sporting heroes should thank their friends 2Health News:Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test) 2Health News:Medco CEO to Present at the Barclays Capital Global Healthcare Conference 2Health News:Animals Respond to Acupuncture's Healing Touch 2Health News:Animals Respond to Acupuncture's Healing Touch 3Health News:Animals Respond to Acupuncture's Healing Touch 4
Bi-Directional doppler volume flowmeter....
... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
One channel transcranial Doppler...
Medicine Products: